Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Calcitonin in the prevention and treatment of osteoporosis.

Literature DB >> 8461562

Calcitonin in the prevention and treatment of osteoporosis.

C H Chestnut¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Analgesics
Calcitonin

Year: 1993 PMID： 8461562 DOI： 10.1007/bf01621908

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

× No keyword cloud information.

5 in total

1. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.

Authors: K Overgaard; M A Hansen; V A Nielsen; B J Riis; C Christiansen
Journal: Am J Med Date: 1990-07 Impact factor: 4.965

2. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors: R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal: J Clin Invest Date: 1988-10 Impact factor: 14.808

3. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.

Authors: K K Pun; L W Chan
Journal: Clin Ther Date: 1989 Mar-Apr Impact factor: 3.393

4. 1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin.

Authors: J Y Reginster; D Denis; A Albert; R Deroisy; M P Lecart; M A Fontaine; P Lambelin; P Franchimont
Journal: Lancet Date: 1987-12-26 Impact factor: 79.321

5. Calcitonin for prevention of postmenopausal bone loss.

Authors: I MacIntyre; J C Stevenson; M I Whitehead; S J Wimalawansa; L M Banks; M J Healy
Journal: Lancet Date: 1988-04-23 Impact factor: 79.321

5 in total

3 in total

Calcitonin in the prevention and treatment of osteoporosis.

1. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.

2. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

3. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.

4. 1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin.

5. Calcitonin for prevention of postmenopausal bone loss.

Review 1. Osteoporosis in inflammatory bowel disease.

2. Effects of Treatment on Endocrine Function in Patients with Epilepsy.

3. Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.